Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-25 @ 7:12 PM
Study NCT ID:
NCT01453205
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2011-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-03
First Submit QC Date:
None
Study First Post Date:
2011-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-05
Results First Submit QC Date:
None
Results First Post Date:
2018-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-07-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-02-08
Last Update Post Date:
2018-03-12
Last Update Post Date Type:
ACTUAL